{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:18:17Z","timestamp":1778199497044,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.yebeh.2019.106648","type":"journal-article","created":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T11:33:26Z","timestamp":1573299206000},"page":"106648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Effects on executive functions of antiepileptic monotherapy in pediatric age"],"prefix":"10.1016","volume":"102","author":[{"given":"Francesca Felicia","family":"Operto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia Maria Giovanna","family":"Pastorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Carotenuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Roccella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Marotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"di Bonaventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Verrotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yebeh.2019.106648_bb0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.seizure.2006.02.013","article-title":"Cognitive side effects of anti-epileptic drugs. The relevance in childhood epilepsy","volume":"15","author":"Lagae","year":"2006","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.yebeh.2019.106648_bb0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1756285611417920","article-title":"The cognitive impact of antiepileptic drugs","volume":"4","author":"Eddy","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"10.1016\/j.yebeh.2019.106648_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/ebeh.2001.0166","article-title":"Factors associated with academic achievement in children with controlled epilepsy","volume":"2","author":"Williams","year":"2001","journal-title":"Epilepsy Behav"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2019.106648_bb0020","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.yebeh.2003.11.004","article-title":"Neuropsychological effects of seizures","volume":"5","author":"Dodrill","year":"2004","journal-title":"Epilepsy Behav"},{"issue":"11","key":"10.1016\/j.yebeh.2019.106648_bb0025","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.euroneuro.2015.07.027","article-title":"Adverse cognitive effects of antiepileptic pharmacotherapy: each additional drug matters","volume":"25","author":"Witt","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.yebeh.2019.106648_bb0030","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.braindev.2017.01.006","article-title":"Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy","volume":"39","author":"Moavero","year":"2017","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2019.106648_bb0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yebeh.2016.04.011","article-title":"Attention and executive functions in the early course of pediatric epilepsy","volume":"60","author":"Reuner","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"12","key":"10.1016\/j.yebeh.2019.106648_bb0040","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/j.1528-1167.2006.00805.x","article-title":"Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy","volume":"47","author":"Hessen","year":"2006","journal-title":"Epilepsia."},{"key":"10.1016\/j.yebeh.2019.106648_bb0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/B978-0-444-52891-9.00073-7","article-title":"Cognitive side-effects of antiepileptic drugs in children","volume":"111","author":"Ijff","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2019.106648_bb0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.spen.2017.10.011","article-title":"Cognitive and behavioral comorbidities: an unwanted effect of antiepileptic drugs in children","volume":"24","author":"Ulate-Campos","year":"2017","journal-title":"Semin Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2019.106648_bb0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.yebeh.2012.09.015","article-title":"Monitoring the cognitive effects of antiepileptic pharmacotherapy\u2014approaching the individual patient","volume":"26","author":"Witt","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2019.106648_bb0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1017\/S1355617707070555","article-title":"Influence of major antiepileptic drugs on neuropsychological function: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients on monotherapy","volume":"13","author":"Hessen","year":"2007","journal-title":"J Int Neuropsychol Soc"},{"issue":"3","key":"10.1016\/j.yebeh.2019.106648_bb0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1600-0404.2008.01109.x","article-title":"Antiepileptic monotherapy significantly impairs normative scores on common tests of executive functions","volume":"119","author":"Hessen","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2019.106648_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.seizure.2018.04.015","article-title":"Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting","volume":"58","author":"Meschede","year":"2018","journal-title":"Seizure."},{"issue":"2","key":"10.1016\/j.yebeh.2019.106648_bb0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s13760-016-0734-y","article-title":"The importance of assessing behaviour and cognition in antiepileptic drug trials in children and adolescents","volume":"117","author":"Lagae","year":"2017","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.yebeh.2019.106648_bb0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yebeh.2019.04.003","article-title":"Evaluating the mediating role of executive functions for antiepileptic drugs' effects on IQ in children and adolescents with epilepsy","volume":"96","author":"Helmstaedter","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2019.106648_bb0085","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.yebeh.2005.08.015","article-title":"EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy","volume":"7","author":"Lutz","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.yebeh.2019.106648_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yebeh.2010.06.042","article-title":"Introduction and first validation of EpiTrack Junior, a screening tool for the assessment of cognitive side effects of antiepileptic medication on attention and executive functions in children and adolescents with epilepsy","volume":"19","author":"Helmstaedter","year":"2010","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2019.106648_bb0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/epi.13671","article-title":"Instruction manual for the ILAE 2017 operational classification of seizure types","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106648_bb0100","series-title":"Coulored progressive matrices (CPM) \u2014 Italian version","author":"Raven","year":"2008"},{"key":"10.1016\/j.yebeh.2019.106648_bb0105","series-title":"Standard progressive matrices (SPM) \u2014 Italian version","author":"Raven","year":"2008"},{"issue":"6","key":"10.1016\/j.yebeh.2019.106648_bb0110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/14656566.2017.1309025","article-title":"How can we overcome neuropsychological adverse effects of antiepileptic drugs?","volume":"18","author":"Witt","year":"2017","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.yebeh.2019.106648_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.971","article-title":"Tested and reported executive problems in children and youth epilepsy","volume":"8","author":"Hessen","year":"2018","journal-title":"Brain Behav"},{"issue":"22","key":"10.1016\/j.yebeh.2019.106648_bb0120","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1212\/01.wnl.0000281104.55418.60","article-title":"Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam","volume":"69","author":"Meador","year":"2007","journal-title":"Neurology."},{"issue":"4","key":"10.1016\/j.yebeh.2019.106648_bb0125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1684\/epd.2008.0227","article-title":"Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study","volume":"10","author":"L\u00f3pez-G\u00f3ngora","year":"2008","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2019.106648_bb0130","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/j.1528-1167.2009.02197.x","article-title":"Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, non-inferiority trial","volume":"50","author":"Levisohn","year":"2009","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.yebeh.2019.106648_bb0135","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa0902014","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy","volume":"362","author":"Glauser","year":"2010","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.yebeh.2019.106648_bb0140","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1212\/WNL.0b013e3182a9f3ca","article-title":"Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy","volume":"81","author":"Masur","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.yebeh.2019.106648_bb0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/WNF.0000000000000038","article-title":"Cognitive and psychosocial effects of oxcarbazepine monotherapy in newly diagnosed partial epilepsy","volume":"37","author":"Kim","year":"2014","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"10.1016\/j.yebeh.2019.106648_bb0150","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.yebeh.2005.07.012","article-title":"Oxcarbazepine monotherapy in benign childhood epilepsy with centrotemporal spikes: a clinical and cognitive evaluation","volume":"7","author":"Tzitiridou","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"9","key":"10.1016\/j.yebeh.2019.106648_bb0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.seizure.2012.07.007","article-title":"A multicenter trial of oxcarbazepine oral suspension monotherapy in children newly diagnosed with partial seizures: a clinical and cognitive evaluation","volume":"21","author":"Eun","year":"2012","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.yebeh.2019.106648_bb0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.yebeh.2009.08.002","article-title":"Impact of antiepileptic drugs on cognition, behavior, and motor skills in children with new-onset, idiopathic epilepsy","volume":"16","author":"Mandelbaum","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106648_bb0165","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.yebeh.2008.11.012","article-title":"The cognitive and psychomotor effects of ramacemide and carbamazepine in newly diagnosed epilepsy","volume":"14","author":"Wesner","year":"2009","journal-title":"Epilepsy Behav"},{"issue":"1\u20132","key":"10.1016\/j.yebeh.2019.106648_bb0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yebeh.2010.02.011","article-title":"Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial","volume":"18","author":"Helmstaedter","year":"2010","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2019.106648_bb0175","doi-asserted-by":"crossref","first-page":"62","DOI":"10.30714\/j-ebr.2019250351","article-title":"The relation between antiepileptic drug type and cognitive functions in childhood epilepsy: a prospective observational study","volume":"2","author":"Hanci","year":"2019","journal-title":"Exp Biomed Res"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019306675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019306675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:29:01Z","timestamp":1761503341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019306675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":35,"alternative-id":["S1525505019306675"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106648","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects on executive functions of antiepileptic monotherapy in pediatric age","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106648"}}